Featured News

Media Contact: Stephanie Bulak info@sidp.org

  • 23 Mar 2015 11:31 PM | Kristi Kuper (Administrator)

    Registration has opened for the 55th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) that will be held in San Diego, California from September 18-21, 2015. In addition, SIDP will be holding their annual meeting on Thursday, September 17th. To register for ICAAC, go to http://www.icaac.org. More information will be forthcoming on how to register for the SIDP meeting.

  • 28 Feb 2015 7:22 AM | Kristi Kuper (Administrator)

    This 2 1/2 day course focuses on new developments and issues related to the use of vaccines. Expert faculty will provide the latest information on both current and prospective vaccines, updated recommendations for vaccinations across the lifespan, and innovative and practical strategies for ensuring timely and appropriate vaccination. The course is specifically designed for physicians (family, infectious disease specialists, internists, and pediatricians), nurse practitioners, nurses, physician assistants, pharmacists, public health professionals, vaccine program administrators, and other healthcare professionals interested in clinical aspects of vaccine delivery.


    This activity has been jointly-planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education by the National Foundation for Infectious Diseases and Emory University School of Medicine. The National Foundation for Infectious Diseases (NFID) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. NFID designates this live activity for a maximum of 19.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Continuing Nursing Education (CNE) and Continuing Pharmacy Education (CPE) credits will also be available.

    Register today at http://www.cvent.com/d/04qyzz/1Q?refid=sidp


  • 28 Feb 2015 6:26 AM | Kristi Kuper (Administrator)

    SIDP is co-organizing an antimicrobial stewardship workshop on Thursday, May 14th from 9am to noon at the Spring SHEA Conference. The conference will be held in Orlando, Florida from May 14-17,2015. The  focus is "science guiding prevention" and has an interprofessional focus on stewardship, as well as implementation science and prevention across the range of healthcare facilities, including hospitals based, community based, and long term care settings.

    SIDP will be co-organizing the Antimicrobial Stewardship Workshop at the SHEA Spring 2015 Conference in May.  http://shea2015.org/  May 14-17th, 2015 in Orlando.  The conference focus “Science Guiding Prevention” has an interprofessional focus on stewardship as well as implementation science and prevention across the range of healthcare facilities, including hospital-based, community-based, and long term care settings.

    SIDP will be co-organizing the Antimicrobial Stewardship Workshop at the SHEA Spring 2015 Conference in May.  http://shea2015.org/  May 14-17th, 2015 in Orlando.  The conference focus “Science Guiding Prevention” has an interprofessional focus on stewardship as well as implementation science and prevention across the range of healthcare facilities, including hospital-based, community-based, and long term care settings.

    SIDP will be co-organizing the Antimicrobial Stewardship Workshop at the SHEA Spring 2015 Conference in May.  http://shea2015.org/  May 14-17th, 2015 in Orlando.  The conference focus “Science Guiding Prevention” has an interprofessional focus on stewardship as well as implementation science and prevention across the range of healthcare facilities, including hospital-based, community-based, and long term care settings.

    SIDP will be co-organizing the Antimicrobial Stewardship Workshop at the SHEA Spring 2015 Conference in May.  http://shea2015.org/  May 14-17th, 2015 in Orlando.  The conference focus “Science Guiding Prevention” has an interprofessional focus on stewardship as well as implementation science and prevention across the range of healthcare facilities, including hospital-based, community-based, and long term care settings.

  • 28 Feb 2015 6:21 AM | Kristi Kuper (Administrator)

    On February 25, 2015, The U.S. Food and Drug Administration approved Avycaz (ceftazidime-avibactam) to treat adults with complicated intra-abdominal infections (cIAI), in combination with metronidazole, and complicated urinary tract infections (cUTI), including kidney infections (pyelonephritis), who have limited or no alternative treatment options.Avycazis a fixed-combination drug containing ceftazidime and avibactam, a new beta-lactamase inhibitor.

      

    See http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm435629.htm for more info.


  • 13 Feb 2015 4:51 PM | Kristi Kuper (Administrator)

    An advisory committee to the US Food and Drug Administration (FDA) voted unanimously to recommend isavuconazonium (ISA) (Cresemba, Astellas Pharma, Inc) for the treatment of adults with invasive aspergillosis (IA) and voted (8 yes, 2 no, 1 abstain) to recommend the drug for the treatment of adults with invasive mucormycosis (IM).http://www.medscape.com/viewarticle/838620


  • 07 Jan 2015 5:52 PM | Kristi Kuper (Administrator)

    January 8, 2015 4pm ET/1pm PT  Cultivating Health January 8, 2015 4pm ET/1pm PT Our gut bacteria shape our health. Dr. Martin Blaser, past president of the Infectious Diseases Society of America (IDSA), explains the connection highlighted in his recent book, Missing Microbes: How the Overuse of Antibiotics is Fueling Our Modern PlaguesDr. Lance Price, microbiologist and public health professor at George Washington University, explores the contribution of industrial meat production, including its reliance on antibiotics. John Billington, Director of Health Policy at the Infectious Diseases Society of America, will discuss the latest antibiotics policy issues. IDSA cosponsors.

    Register at : https://attendee.gotowebinar.com/register/6416201563699806977

  • 07 Jan 2015 5:43 PM | Kristi Kuper (Administrator)
    BioCryst's RAPIVAB(TM) (peramivir injection) Receives FDA Approval for the Treatment of Acute Uncomplicated Influenza. See http://rapivab.com/prescribing-information/


  • 05 Dec 2014 9:43 AM | Christopher McCoy (Administrator)

    For those that may wear an Infection Control hat or want to buff up on rapid diagnostics, a webinar is being offered at 1p (EST).  Registration is available at this site.  Details below:


    Date: Wednesday, December 10, 2014
    Time: 1:00–2:00 PM Eastern (US) Time

    Reducing healthcare–associated infections requires an integrated effort from all staff responsible for patient care, including laboratorians. This presentation will discuss the laboratory’s critical role in this endeavor, as well as important diagnostic tests that can facilitate infection control decisions.

    At the end of this program, participants will be able to:

    • • Locate recommendations from the Centers for Disease Control and Prevention for infection control of multidrug-resistant pathogens.
    • • Identify infection control decisions that are most likely to require special laboratory testing.
    • • List tests that can guide infection control decisions.

    Speaker:
    Jean B. Patel, PhD, D(ABMM)
    Centers for Disease Control and Prevention
    Atlanta, Georgia, USA

    Learning Level: Intermediate

    Related Document: AST documents

    $99.00 for non-members (member discounts apply)

Membership gives you more

  • Access exclusive opportunities
  • Connect with colleagues
  • Attend networking events

JOIN TODAY


Society of Infectious Diseases Pharmacists • 823 Congress Avenue, Suite 230 Austin, Texas 78701 • (512) 328-8632


Powered by Wild Apricot Membership Software